Syndicate content

Exosome Market Dynamics Report Published by GEN

“Exosome Market Dynamics, Part 1” produced by Select Biosciences was published on June 22, 2015 by Genetic Engineering &Technology News (GEN). Authored by Enal Razvi, Ph.D., and Gary Oosta, Ph.D., this report represents the first of three reports on the exosome marketplace that GEN plans on publishing. This first report is the Select Biosciences industry analysis on exosomes, focusing on the technology trends and evolution of this field. The report describes the penetrance of different technologies into the exosomes space and frame this into the overall evolution of this field—indeed, the utilization of different technology platforms foretells the expansion of specific segments—e.g., RNA cargo analysis vs protein cargo analysis derived from exosomes. In GEN’s belief, these data frame the big picture of the exosomes field. In the next report on this topic, GEN will be exploring the specific biomarkers that have been studied in exosomes/extracellular vesicles thus far. The entire report can be accessed at the link provided below. With regard to the authors, Enal Razvi, Ph.D., conducted his doctoral work on viral immunology and, subsequent to receiving his Ph.D., went on to the Rockefeller University in New York to serve as Aaron Diamond Post-Doctoral fellow under Professor Ralph Steinman (Nobel Prize Winner in 2011 for his discovery of dendritic cells in the early-70s with Dr. Zanvil Cohn). Subsequently, Dr. Razvi completed his research fellowship at Harvard Medical School. For the last two decades Dr. Razvi has worked with small and large companies and consulted for more than 100 clients worldwide. He currently serves as Biotechnology Analyst and Managing Director of SelectBio U.S. He can be reached at Gary M. Oosta holds a Ph.D. in Biophysics from Massachusetts Institute of Technology and a B.A. in Chemistry from Eastern Michigan University He has 25 years of industrial research experience in various technology areas including medical diagnostics, thin-layer coating, bio-effects of electromagnetic radiation, and blood coagulation. Dr. Oosta has authored 20 technical publications and is an inventor on 77 patents worldwide. In addition, he has managed research groups that were responsible for many other patented innovations. Dr. Oosta has a long-standing interest in using patents and publications as strategic technology indicators for future technology selection and new product development.

[Exosome Market Dynamics, Part 1--Full Report] [GEN announcement]